We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+8.27%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$5.6B
AUM Growth
+$769M
Cap. Flow
+$469M
Cap. Flow %
8.38%
Top 10 Hldgs %
13.16%
Holding
1,266
New
125
Increased
352
Reduced
429
Closed
264

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$58.9M
2
EOG icon
EOG Resources
EOG
+$37.7M
3
YUM icon
Yum! Brands
YUM
+$29.2M
4
A icon
Agilent Technologies
A
+$25.5M
5
OXY icon
Occidental Petroleum
OXY
+$24.6M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$27.1M
2
ICE icon
Intercontinental Exchange
ICE
+$26M
3
GPN icon
Global Payments
GPN
+$24.2M
4
CDNS icon
Cadence Design Systems
CDNS
+$22.8M
5
AAPL icon
Apple
AAPL
+$22.7M

Sector Composition

Rank Sector Weight
1 Technology 19.55%
2 Financials 15.15%
3 Healthcare 14.96%
4 Consumer Discretionary 10.52%
5 Industrials 10.08%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DSCI
776
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
$355K 0.01%
76,072
-16,300
-18% -$76.1K
MGI
777
DELISTED
MoneyGram International, Inc. New
MGI
$352K 0.01%
+49,528
New +$353K
EGIO
778
DELISTED
Edgio, Inc. Common Stock
EGIO
$348K 0.01%
4,653
-303
-6% -$20.5K
GSBC icon
779
Great Southern Bancorp
GSBC
$863M
$346K 0.01%
8,500
– –
SFLY
780
DELISTED
Shutterfly, Inc.
SFLY
$345K 0.01%
7,720
-4,480
-37% -$222K
CTIC
781
DELISTED
CTI BioPharma Corp. (DE) Common Stock
CTIC
$344K 0.01%
91,920
-24,970
-21% -$90.9K
MCHX icon
782
Marchex
MCHX
$79.7M
$341K 0.01%
123,263
– –
RYZ
783
Ryerson Holding Corp
RYZ
$1.6B
$339K 0.01%
30,027
-1,200
-4% -$16.2K
PFSI icon
784
PennyMac Financial
PFSI
$4.38B
$337K 0.01%
19,790
-700
-3% -$10.6K
CVO
785
DELISTED
Cenevo, Inc.
CVO
$336K 0.01%
47,648
-4,003
-8% -$29.8K
SNA icon
786
Snap-on
SNA
$20.9B
$333K 0.01%
2,190
– –
AMWD
787
DELISTED
American Woodmark
AMWD
$332K 0.01%
4,120
+320
+8% +$25K
CDI
788
DELISTED
CDI Corp.
CDI
$332K 0.01%
58,503
-12,300
-17% -$72.1K
NHI icon
789
National Health Investors
NHI
$3.9B
$330K 0.01%
4,200
– –
DRNA
790
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$328K 0.01%
55,719
-38,700
-41% -$136K
ACN icon
791
Accenture
ACN
$89.9B
$326K 0.01%
+2,670
New +$304K
HIVE
792
DELISTED
Aerohive Networks
HIVE
$325K 0.01%
53,300
– –
NSTG
793
DELISTED
NanoString Technologies, Inc.
NSTG
$324K 0.01%
16,200
+3,400
+27% +$54K
CNCE
794
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$322K 0.01%
31,852
+5,016
+19% +$54.8K
PTLA
795
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$322K 0.01%
14,200
-123,630
-90% -$2.9M
VRA icon
796
Vera Bradley
VRA
$105M
$321K 0.01%
21,180
-5,948
-22% -$89.3K
FARO
797
DELISTED
Faro Technologies
FARO
$320K 0.01%
+8,890
New +$302K
UNM icon
798
Unum
UNM
$13.8B
$320K 0.01%
9,070
-75,760
-89% -$2.56M
MNK
799
DELISTED
MALLINCKRODT PUBLIC LIMITED COMPANY
MNK
$320K 0.01%
4,590
-155,240
-97% -$11.2M
ARC
800
DELISTED
ARC Document Solutions, Inc.
ARC
$319K 0.01%
85,164
-46,488
-35% -$168K
30 31
32
33 34

Similar funds

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Teacher Retirement System of Texas
Teacher Retirement System of Texas Austin, Texas $24B AUM 29.51% 1-Year Est. Return
Walleye Capital
Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return
CHP
Castle Hook Partners New York $23.4B AUM 158.96% 1-Year Est. Return
SAM
SEB Asset Management Stockholm $23.4B AUM
JG
Jain Global New York $24.2B AUM 34.82% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

Jacobs Levy Equity Management's Q3 2016 Portfolio in Review

As of Q3 2016, Jacobs Levy Equity Management held 1,266 positions worth $5.6B, up 16% from $4.83B the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Jacobs Levy Equity Management deployed $469M of net new capital in Q3 2016, opening 125 new positions and adding to 352 existing holdings. Its largest new stake was Bristol-Myers Squibb: 916,932 shares worth $49.4M.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Intercontinental Exchange, an estimated $26M trimmed.

  • Jacobs Levy Equity Management's largest Q3 2016 buy was Bristol-Myers Squibb: 916,932 shares worth $49.4M.
  • Jacobs Levy Equity Management added most to Agilent Technologies in Q3 2016, an estimated $25.5M increase.
  • Jacobs Levy Equity Management's biggest Q3 2016 reduction was Intercontinental Exchange, cutting an estimated $26M.
  • Jacobs Levy Equity Management fully exited Gen Digital in Q3 2016, selling an estimated $27.1M.
  • Jacobs Levy Equity Management's ten largest holdings make up 13% of its $5.6B portfolio in Q3 2016.
  • Jacobs Levy Equity Management opened 125 new positions and closed 264 in Q3 2016.
  • Jacobs Levy Equity Management's portfolio value rose 16% quarter-over-quarter to $5.6B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2016, filed 14 Nov 2016.